Evaluation of Salivary Gland Dysfunction
Launched by NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH (NIDCR) · Nov 3, 1999
Trial Information
Current as of May 09, 2025
Terminated
Keywords
ClinConnect Summary
This study will evaluate participants with complaints of dry mouth to determine the cause and severity of their salivary gland dysfunction and their possible eligibility for other NIDCR protocols. Salivary secretions have antibacterial, lubricating, remineralizing, digestive, buffering and cleansing properties. Impaired function of these glands can cause an increase in tooth decay; a variety of oral hard and soft tissue changes, with painful, burning or ulcerated or oral mucosa; problems chewing, swallowing and speaking; and diminished taste and smell.
Participants with dry mouth complaint...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • 1. Subjects must have dry mouth symptoms (xerostomia) or a reasonable clinical suspicion of having Sj(SqrRoot)(Delta)gren s syndrome or other salivary gland disease
- • 2. Ability to provide informed consent.
- EXCLUSION CRITERIA:
- • a. Age less than 12 years.
About National Institute Of Dental And Craniofacial Research (Nidcr)
The National Institute of Dental and Craniofacial Research (NIDCR) is a pivotal component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of dental and craniofacial disorders. Through innovative research and clinical trials, NIDCR aims to enhance oral health and improve the quality of life for individuals affected by these conditions. The institute fosters collaboration among scientists, clinicians, and public health professionals to translate research findings into practical applications, ensuring that the latest advancements benefit patients and communities. With a commitment to excellence in research and education, NIDCR plays a critical role in shaping the future of oral health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Ilias G Alevizos, D.M.D.
Principal Investigator
National Institute of Dental and Craniofacial Research (NIDCR)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials